Mutagenesis vol. 19 no. 2 pp. 105-119,
March 2004
© 2004 UK Environmental Mutagen Society/Oxford University Press
The GreenScreen® genotoxicity assay: a screening validation programme
Department of Biomolecular Sciences, UMIST, Manchester M60 1QD, UK and 1Genetics Department, University of Wales Swansea, Singleton Park, Swansea SA2 8PP, UK
A yeast (Saccharomyces cerevisiae) DNA repair reporter assay termed the GreenScreen® assay (GSA) is described. This is a novel, cost-effective genotoxicity screen, developed to provide a pre-regulatory screening assay for use by the pharmaceutical industry and in other applications where significant numbers of compounds need to be tested. It provides a higher throughput and a lower compound consumption than existing eukaryotic genotoxicity assays and is sensitive to a broad spectrum of mutagens and, importantly, clastogens. We describe a simple, robust assay protocol and a validation study. The end-point of the test reflects the typically eukaryotic chromosomes and DNA metabolizing enzymes of yeast. The capacity for metabolic activation (MA) in yeast is limited compared with the mammalian liver or its extracts, but the assay does detect a subset of compounds that would require MA in existing genotoxicity tests. The GSA detects a different spectrum of compounds to bacterial genotoxicity assays and thus, together with an in silico structure–activity relationship (SAR) screen, and possibly a high throughput bacterial screen, would provide an effective preview of the regulatory battery of genotoxicity tests.
2To whom correspondence should be addressed. Tel: +44 161 200 4174; Fax: +44 161 236 0409; Email: richard.walmsley{at}umist.ac.uk
Received on May 27, 2003; revised on October 6 and December 18, 2003; accepted on December 18, 2003
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. W. Knight, L. Birrell, and R. M. Walmsley Development and Validation of a Higher Throughput Screening Approach to Genotoxicity Testing Using the GADD45a-GFP GreenScreen HC Assay J Biomol Screen, January 1, 2009; 14(1): 16 - 30. [Abstract] [PDF]
|
|
|
|
 |
|
 A. W. Knight, N. Billinton, P. A. Cahill, A. Scott, J. S. Harvey, K. J. Roberts, D. J. Tweats, P. O. Keenan, and R. M. Walmsley An analysis of results from 305 compounds tested with the yeast RAD54-GFP genotoxicity assay (GreenScreen GC) including relative predictivity of regulatory tests and rodent carcinogenesis and performance with autofluorescent and coloured compounds Mutagenesis, November 1, 2007; 22(6): 409 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Futakami, M. Salimullah, T. Miura, S. Tokita, and K. Nishigaki Novel Mutation Assay with High Sensitivity based on Direct Measurement of Genomic DNA Alterations: Comparable Results to the Ames Test J. Biochem., May 1, 2007; 141(5): 675 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ichikawa and T. Eki A Novel Yeast-Based Reporter Assay System for the Sensitive Detection of Genotoxic Agents Mediated by a DNA Damage-Inducible LexA-GAL4 Protein J. Biochem., January 1, 2006; 139(1): 105 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Van Gompel, F. Woestenborghs, D. Beerens, C. Mackie, P.A. Cahill, A.W. Knight, N. Billinton, D.J. Tweats, and R.M. Walmsley An assessment of the utility of the yeast GreenScreen assay in pharmaceutical screening Mutagenesis, November 1, 2005; 20(6): 449 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Walsh, P.W. Hastwell, P.O. Keenan, A.W. Knight, N. Billinton, and R.M. Walmsley Genetic modification and variations in solvent increase the sensitivity of the yeast RAD54-GFP genotoxicity assay Mutagenesis, September 1, 2005; 20(5): 317 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. L. Martin and K. T. Semple Environmental health impacts: occurrence, exposure and significance, Lancaster University, UK, 9-10 September 2003 Mutagenesis, September 1, 2004; 19(5): 423 - 429. [Abstract] [Full Text] [PDF]
|
|